Have a personal or library account? Click to login
Inhaled sevoflurane in critically ill COVID-19 patients: A retrospective cohort study Cover

Inhaled sevoflurane in critically ill COVID-19 patients: A retrospective cohort study

Open Access
|Jan 2026

References

  1. Loza A, Wong-Chew RM, Jimenez-Corona M-E, et al. Two-year follow-up of the COVID-19 pandemic in Mexico. Front Public Health. 2022;10:1050673.
  2. Olivas-Martinez A, Cardenas-Fragoso JL, Jimenez JV, et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PLoS One. 2021;16(2):e0245772.
  3. Cortes-Telles A, Figueroa-Hurtado E, Ortiz-Farias DL, et al. Modeling mortality risk in patients with severe COVID-19 from Mexico. Front Med (Lausanne). 2023;10:1187288.
  4. Kim H, Lee J, Kim H, et al. Volatile sedation in the intensive care unit: A systematic review and meta-analysis. Medicine [Internet]. 2017 [cited 2021 Aug 17];96(49).
  5. Jerath A, Panckhurst J, Parotto M, et al. Safety and Efficacy of Volatile Anesthetic Agents Compared With Standard Intravenous Midazolam/Propofol Sedation in Ventilated Critical Care Patients: A Meta-analysis and Systematic Review of Prospective Trials. Anesth Analg [Internet]. 2017 [cited 2021 Aug 17];124(4):1190–1199.
  6. Farrell R, Oomen G, Carey P. A technical review of the history, development and performance of the anaesthetic conserving device “AnaConDa” for delivering volatile anaesthetic in intensive and post-operative critical care. J Clin Monit Comput [Internet]. 2018 [cited 2021 Aug 17];32(4):595–604.
  7. Nwabufo CK. Uncovering the Impact of COVID-19 Mediated Bidirectional Dysregulation of CYP3A4 on Systemic and Pulmonary Drug Concentrations Using Physiologically Based Pharmacokinetic Modeling. Drug Metab Dispos. 2024;52(12).
  8. Delgado A, Stewart S, Urroz M, et al. Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals. J Clin Med. 2021;10(19).
  9. Soukup J, Selle A, Wienke A, et al. Efficiency and safety of inhalative sedation with sevoflurane in comparison to an intravenous sedation concept with propofol in intensive care patients: study protocol for a randomized controlled trial. Trials [Internet]. 2012 [cited 2021 Aug 17];13.
  10. Beck-Schimmer B, Schadde E, Pietsch U, et al. Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial. Ann Intensive Care. 2024;14(1):41.
  11. Migliari M, Bellani G, Rona R, et al. Short-term evaluation of sedation with sevoflurane administered by the anesthetic conserving device in critically ill patients. Intensive Care Med [Internet]. 2009 [cited 2021 Aug 17];35(7):1240–1246.
  12. Mesnil M, Capdevila X, Bringuier S, et al. Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Med [Internet]. 2011 [cited 2021 Aug 17];37(6):933–941.
  13. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703–2710.
  14. Landoni G, Belloni O, Russo G, et al. Inhaled Sedation for Invasively Ventilated COVID-19 Patients: A Systematic Review. J Clin Med. 2022;11(9).
  15. Gomez Duque M, Medina R, Enciso C, et al. Usefulness of Inhaled Sedation in Patients With Severe ARDS Due to COVID-19. Respir Care. 2023;68(3):293–299.
  16. Soukup J, Michel P, Christel A, et al. Prolonged sedation with sevoflurane in comparison to intravenous sedation in critically ill patients - A randomized controlled trial. J Crit Care. 2023;74:154251.
  17. Cuninghame S, Jerath A, Gorsky K, et al. Effect of inhaled anaesthetics on cognitive and psychiatric outcomes in critically ill adults: a systematic review and meta-analysis. Br J Anaesth. 2023;131(2):314–327.
  18. Taylor J, Payne T, Casey C, et al. Sevoflurane dose and postoperative delirium: a prospective cohort analysis. Br J Anaesth. 2023;130(2):e289–e297.
  19. Foudraine NA, Algargoush A, van Osch FH, et al. A multimodal sevoflurane-based sedation regimen in combination with targeted temperature management in post-cardiac arrest patients reduces the incidence of delirium: An observational propensity score-matched study. Resuscitation. 2021;159:158–164.
  20. Acharya NK, Goldwaser EL, Forsberg MM, et al. Sevoflurane and Isoflurane induce structural changes in brain vascular endothelial cells and increase blood-brain barrier permeability: Possible link to postoperative delirium and cognitive decline. Brain Res. 2015;1620:29–41.
  21. Strosing KM, Faller S, Gyllenram V, et al. Inhaled Anesthetics Exert Different Protective Properties in a Mouse Model of Ventilator-Induced Lung Injury. Anesth Analg. 2016;123(1):143–151.
  22. Xiong X, Lin L, Wang L, et al. Sevoflurane attenuates pulmonary inflammation and ventilator-induced lung injury by upregulation of HO-1 mRNA expression in mice. Int J Nanomedicine. 2013;6:1075–1081.
  23. Chabanne R, Perbet S, Futier E, et al. Impact of the anesthetic conserving device on respiratory parameters and work of breathing in critically ill patients under light sedation with sevoflurane. Anesthesiology. 2014;121(4):808–816.
  24. Aberegg SK. Ionized Calcium in the ICU: Should It Be Measured and Corrected? Chest. 2016;149(3):846–855.
  25. Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20(10):1135–1140.
  26. Bellani G, Laffey JG, Pham T, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315(8):788–800.
  27. Jerath A, Parotto M, Wasowicz M, et al. Volatile Anesthetics. Is a New Player Emerging in Critical Care Sedation? Am J Respir Crit Care Med. 2016;193(11):1202–1212.
DOI: https://doi.org/10.2478/jccm-2026-0011 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 84 - 94
Submitted on: Apr 11, 2025
|
Accepted on: Jan 16, 2026
|
Published on: Jan 30, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Jose J. Zaragoza, Marco A. Baez-Garcia, Jose M. Lomeli-Teran, Daniela Anzures-Diaz, Paola Zamudio-Cantellano, Job H. Rodriguez-Guillen, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.